These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1820869)

  • 1. A derivation of mean residence time.
    Becker R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():15-6. PubMed ID: 1820869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.
    Cheng HY; Jusko WJ
    Pharm Res; 1988 Mar; 5(3):156-64. PubMed ID: 3244627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
    Rohatagi S; Kan S; Derendorf H
    Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of diclofenac and its interaction with enrofloxacin in sheep.
    Rahal A; Kumar A; Ahmad AH; Malik JK
    Res Vet Sci; 2008 Jun; 84(3):452-6. PubMed ID: 17692878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equation.
    Volosov A; Bialer M
    Biopharm Drug Dispos; 1999 Jan; 20(1):3-9. PubMed ID: 10086832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
    Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
    Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of terbutaline after parenteral administration.
    Fagerström PO
    Eur J Respir Dis Suppl; 1984; 134():101-10. PubMed ID: 6586470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of absorption rates in bioequivalence studies of immediate release drug formulations.
    Schall R; Luus HG
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):153-9. PubMed ID: 1592542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN; Jusko WJ
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between in silico physicochemical characteristics of drugs and their mean residence time in human and dog.
    Grabowski T; Jaroszewski JJ; Gad SC; Feder M
    Int J Toxicol; 2012; 31(1):25-33. PubMed ID: 22215410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and food interaction of MK-462 in healthy males.
    Cheng H; Polvino WJ; Sciberras D; Yogendran L; Cerchio KA; Christie K; Olah TV; McLoughlin D; James I; Rogers JD
    Biopharm Drug Dispos; 1996 Jan; 17(1):17-24. PubMed ID: 8991488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Michaelis-Menten elimination kinetics of acetate during ethanol oxidation.
    Fujimiya T; Li YJ; Ohbora Y
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):16S-20S. PubMed ID: 10803773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependent pharmacokinetics of naproxen in man.
    Niazi SK; Alam SM; Ahmad SI
    Biopharm Drug Dispos; 1996 May; 17(4):355-61. PubMed ID: 8743406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.